Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2014
11/25/2014US8895561 Compounds and methods for treating candidiasis and aspergillus infections
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/20/2014US20140343118 Methods of treatment using arylcyclopropylamine compounds
11/20/2014US20140343108 Oleanolic acid amidate derivatives, preparation methods and uses thereof
11/18/2014US8889888 Sulfonic acid salt and derivative thereof, photo-acid generator, and process for production of sulfonic acid salt
11/18/2014US8889732 Fused heterocyclic compounds and thrombopoietin receptor activators
11/13/2014US20140336178 Compositions and methods for modulating interaction between polypeptides
11/13/2014US20140336137 Novel nitroso compounds as nitroxyl donors and methods of use thereof
11/11/2014US8884030 Inhibitors of Flaviviridae viruses
11/11/2014US8883846 Synthesis of bicyclic compounds and method for their use as therapeutic agents
11/11/2014US8883824 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/11/2014US8883781 Thienopyrimidines useful as modulators of ion channels
11/06/2014US20140330026 2-fluorophenyl propionic acid derivatives
11/06/2014US20140329802 Tetrahydrobenzothiophene compound
11/04/2014US8877975 Cycloalkylamines as monoamine reuptake inhibitors
11/04/2014US8877969 Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
11/04/2014US8877805 Heteroarylcarboxylic acid ester derivative
11/04/2014US8877801 Compounds and compositions as selective estrogen receptor degraders
11/04/2014US8877784 TRPA1 antagonists
10/2014
10/30/2014US20140323736 Use of aryl and hetaryl carboxamides as endoparasiticides
10/30/2014US20140323558 Therapeutic agents
10/30/2014US20140323530 Amine derivative compounds for treating ophthalmic diseases and disorders
10/30/2014US20140323518 Novel estrogen receptor ligands
10/30/2014US20140323510 Substituted arylcyclopentenes as therapeutic agents
10/30/2014US20140323502 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
10/30/2014US20140323487 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors
10/30/2014US20140319331 New use for a compound as a matrix in the specific detection, identification and/or quantification of alkaloids by maldi-tof mass spectrometry
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871976 Chalcone structure fluorescence dye for embryonic stem cell probe
10/28/2014US8871952 Thiophene compounds for liquid-crystalline media
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871903 Palladium catalyzed reactions executed on solid-phase peptide synthesis supports for the production of self-assembling peptides embedded with complex organic electronic subunits
10/23/2014US20140315965 Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer
10/23/2014US20140315899 Sulfonamides as trpm8 modulators
10/23/2014US20140315898 N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
10/21/2014US8866135 Anthracene derivative and organic electroluminescent element using the same
10/21/2014US8865919 Sulfonium compound, photo-acid generator, and method for manufacturing the same
10/21/2014US8865754 Compounds for the treatment of neurodegenerative diseases
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865624 Inhibitor for tobacco axillary bud growth and method for inhibiting tobacco axillary bud growth
10/16/2014US20140309274 Lipidic Furan, Pyrrole, and Thiophene Compounds for Treatment of Cancer, Neurological Disorders, and Fibrotic Disorders
10/16/2014US20140309264 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
10/14/2014US8859812 Compound reagents and method for synthesizing enantiomerically enriched amino acids
10/14/2014US8859802 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/14/2014US8859611 Thiophene inhibitors of S-nitrosoglutathione reductase
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859111 Materials for organic electroluminescent devices
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014163305A1 Compound for organic electronic element, organic electronic element using same, and electronic device thereof
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303150 Ingenol-3-acylates iii and ingenol-3-carbamates
10/09/2014US20140302069 Modulators of c3a receptors
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2786983A1 Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof
10/08/2014EP2785704A1 Novel combination of n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide and folfox
10/07/2014US8853441 Sulfonium compound, photoacid generator, and resist composition
10/07/2014US8853424 Protein cross-linking inhibitor
10/07/2014US8852937 Small organic molecule regulators of cell proliferation
10/07/2014US8852756 Materials for organic electroluminescent devices
10/02/2014WO2014160940A2 Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
10/02/2014WO2014160649A1 Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
10/02/2014WO2014159054A1 Gpr120 agonists for the treatment of type ii diabetes
10/02/2014WO2014158654A1 Ship1 modulators and methods related thereto
10/02/2014WO2014157238A1 Photoelectric conversion material, photoelectric conversion element and method for using same, optical sensor, and image pickup element
10/02/2014WO2014157216A1 Photoelectric conversion material, photoelectric transducer and method of using said transducer, light sensor, and imaging element
10/02/2014WO2014157018A1 Organic compound, light-emitting element, light-emitting device, display device, electronic device, and lighting device
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014US20140296256 Plasminogen activator inhibitor-1 inhibitor
10/01/2014EP2784061A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof
09/2014
09/30/2014US8846955 Second-order nonlinear optical compound and nonlinear optical element comprising the same
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846762 Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
09/30/2014US8846747 Compounds and methods for altering lifespan of eukaryotic organisms
09/30/2014US8846214 Amine derivative and organic electroluminescent element
09/30/2014CA2763786C Alkanoylamino benzamide aniline hdac inihibitor compounds
09/25/2014WO2014148053A1 Use of ep4 receptor antagonists in the treatment of cartilage disease
09/25/2014US20140288230 Methylene beta-ketoester monomers, methods for making methylene beta-ketoester monomers, polymerizable compositions and products formed therefrom
09/25/2014US20140288145 Treatment of amyloidosis by compounds that regulate retromer stabilization
09/23/2014CA2628413C Prostaglandins and analogues as agents for lowering intraocular pressure
09/18/2014WO2014142219A1 Guanidinobenzoic acid ester compound
09/18/2014WO2014138833A1 Compounds, use, pharmaceutical composition for inhibiting reductase in microorganisms, inha binder and method for obtaining inha binders
09/18/2014US20140275400 Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
09/18/2014US20140275179 Gpr120 agonists for the treatment of type ii diabetes
09/18/2014US20140275172 Benzo-fused heterocyclic derivatives useful as agonists of gpr120
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275088 Small molecule malarial aldolase-trap enhancers and glideosome inhibitors
09/18/2014US20140275043 Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
09/18/2014US20140275008 Compounds and uses thereof for the modulation of hemoglobin
09/17/2014EP2778158A1 Sulfolane mixtures as ambient aprotic polar solvents
09/17/2014EP2776411A1 Modulators of c3a receptors
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835682 Alkaloid aminoester derivatives and medicinal composition thereof
09/16/2014US8835654 Method and compositions for treating amyloid-related diseases
09/16/2014US8835644 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
09/16/2014US8835476 Synthesis of novel antimicrobials
09/12/2014WO2014137301A1 Hydrazones and thiazolidinones derived from diflunisal
09/12/2014WO2014136122A1 Process for the preparation of rotigotine polymorphic form-i
09/12/2014WO2014135834A1 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 329